|
HS Code |
342451 |
As an accredited 7-Bromoquinoxalin-2(1H)-One factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 7-Bromoquinoxalin-2(1H)-One prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemists and scientists know the relentless search for molecules that can open new doors in drug discovery, material science, and analytical research. 7-Bromoquinoxalin-2(1H)-one offers more than a single-purpose application: this compound emerges from the robust quinoxaline family, bringing with it a mix of versatility and intriguing chemical features that distinguish it among research chemicals.
What draws attention is not just the inclusion of a bromine atom at the seventh position—though this subtle change shapes both physical and chemical behavior—it’s the knock-on effects this structure brings in synthetic processes and its observable influence on biological studies. To anyone who’s spent time in a lab, structural tweaks like bromination at a selective site can transform a synthetic intermediate into an indispensable tool for modifying drug candidates, advancing new diagnostic methods, or crafting tailored fluorophores.
7-Bromoquinoxalin-2(1H)-one doesn’t try to hide its strengths. The molecule features a rigid fused aromatic system topped by a bromine atom, and that single halogen step can dictate patterns of reactivity, leaving chemists with avenues unavailable to its non-brominated cousins. Scientists in medicinal chemistry appreciate the balance between molecular stability and functional handle. It matters especially during the demanding reactions required for attaching linkers, building new derivatives, or triggering one-pot transformations.
Researchers usually reach for 7-Bromoquinoxalin-2(1H)-one in crystalline powder form. Purity forms the backbone of experimental consistency, with reputable lots often graded at 98% or higher. This high purity presents fewer headaches around side impurities or batch variability—something anyone who’s seen an unexpected spot on a TLC plate will respect. With a predictable melting point in the approximate range expected for rigid-aromatic brominated compounds, storage becomes straightforward and safe, avoiding surprise decomposition. While details can differ slightly batch by batch, these features speak directly to researchers who depend on reliable behavior from each bottle.
In my own experience, quinoxalinones have stood at the intersection of many fields, and 7-Bromoquinoxalin-2(1H)-one is no exception. Academic labs and industry R&D teams both look toward this compound for its ease in cross-coupling, suzuki, or nucleophilic substitution reactions. As a halogenated building block, the bromine at position seven practically begs to be replaced under the right conditions, providing a foothold to pull in alkyl, aryl, or heterocyclic groups, merging new motifs onto the rigid quinoxaline platform.
It’s not just an asset for synthetic organic chemists. Biochemists and molecular biologists use these quinoxalinone derivatives as scaffolds in probing enzyme inhibitors or receptor modulators. Several approved drugs trace their origins to quinoxaline frameworks, so early-stage analogs like 7-Bromoquinoxalin-2(1H)-one often end up in screening assays, SAR (structure-activity relationship) campaigns, and fragment-based discovery programs.
The compound has also found a foothold in the materials science world, latching onto the growing push for organic optoelectronics. By leveraging its aromatic backbone and bromine’s electron-withdrawing influence, researchers build new molecules with tailored electronic properties, fine-tuned light absorption, and emission characteristics. This background informs why some chemical engineers turn to 7-Bromoquinoxalin-2(1H)-one when mapping out organic semiconductors or specialized dyes.
Not all quinoxalinones serve up the same menu of applications. Take the non-brominated version: while it shares a core structure, its reactivity diverges markedly. Bromine atoms provide a crucial site for chemical modification, especially when handling more elaborate reactions. In direct comparison, 7-Bromoquinoxalin-2(1H)-one’s additional functional handle translates to a broader reaction palette—think carbon-carbon bond forming reactions, such as Suzuki-Miyaura or Sonogashira couplings, that simply aren’t feasible on the parent, unsubstituted compound.
Many in the field notice the added advantage: a halogen at a defined site enables chemoselective transformations, which means you can install precise changes without scrambling the rest of the molecule. This not only cuts down on unwanted by-products but also helps route synthesis toward specific, high-value targets. These features make the brominated analogs like this one highly attractive candidates for medicinal chemistry campaigns, where lead diversification offers the best shot at unearthing novel biological activity.
Another clear difference appears during purification and analytical work. The heavier atom can tweak chromatographic retention or NMR spectral signatures in subtle but helpful ways. Anyone who’s tried hunting trace impurities by NMR or mass spectrometry welcomes little bonuses like these. Physical chemists and analytical teams using LC-MS (liquid chromatography-mass spectrometry) or HPLC (high-performance liquid chromatography) leverage these properties for sharper separations and easier peak assignments.
Here’s something any researcher can agree on: reliability in handling wins more fans than eye-catching molecular models. 7-Bromoquinoxalin-2(1H)-one generally stores well in dry, cool conditions, and doesn’t demand special atmospheric controls for most routine bench work. Since it’s not a volatile compound, spill risk rarely rises above standard protocols. Gloves, safety glasses, and a well-ventilated workspace give more than enough peace of mind during usage.
As with many research chemicals, the lack of ubiquitous performance in humans and the environment calls for extra care during disposal. Those responsible for chemical waste take the same approach as with any brominated heterocycles: neutralization and deactivation according to current regulatory standards. Chemists who face production-scale projects where kilogram quantities enter the workflow know that robust safety documentation and clear protocols spell the difference between smooth operation and unforeseen setbacks.
The value of 7-Bromoquinoxalin-2(1H)-one doesn’t fade when zooming out to the broader context. Drug discovery teams, whether grafted onto universities or embedded in pharma, often operate with fierce deadlines and exacting standards. War stories from late hours in the lab reinforce a simple truth: a reliable intermediate shaves weeks off lead optimization. Missing purity or inconsistent reactivity adds layers of repetition, wasted reagents, and lost morale. The track record of this compound in coupling chemistry and fragment expansion strengthens its case as an indispensable addition to the modern laboratory arsenal.
Material scientists, too, see recurring wins. As organic electronics and sensor technologies press for more reliable organic semiconductors, the need for customizable aromatic frameworks goes up. Quinoxaline derivatives serve as the core of many light-emitting diodes and photovoltaic devices—here, the ability to install new substituents via selective halogen chemistry often spells the difference between iterative tweaking and meaningful innovation.
Some research groups share tales of failed grant applications or shelved projects, all for want of solid, reproducible intermediates. 7-Bromoquinoxalin-2(1H)-one often steps in as the answer, providing a single, isolable compound from which a battery of derivatives springs. This isn’t theoretical—productivity strengthens when synthetic hurdles give way to robust, predictable transformations.
Beyond my own lab experiences, colleagues across continents highlight achievements powered by 7-Bromoquinoxalin-2(1H)-one. Early studies into kinase inhibitors, for instance, took leaps forward because chemists could rapidly decorate the quinoxaline core with various groups, isolating promising hits in biological assays with fewer synthetic steps. Year after year, the literature builds on these analogs, extending into more diverse therapeutic areas—oncology, antivirals, and neuroactive agents—tracing breakthroughs to a pool of reliable intermediates like this one.
Diagnostic researchers aiming for sharper imaging or improved analytical probes also rely increasingly on quinoxaline-derived dyes. With the rise in demand for precision imaging, new variants often start from halogenated frameworks, in part because bromine’s presence facilitates further modification and can influence photophysical behaviors. As new imaging modalities pop up in both hospital settings and research clinics, scientists want backbone structures that combine synthetic agility with predictable behavior.
Sustainability and green chemistry have carved out their own domains, and the role of effective chemical intermediates cannot be downplayed. In sustainable synthesis, minimizing steps and reducing hazardous by-products begin with molecules amenable to selective reactions. 7-Bromoquinoxalin-2(1H)-one, with its tendency for targeted substitution, enables convergent syntheses—fewer steps, lower waste, less energy consumed. Environmental stewardship in the chemical industry depends as much on smart building blocks as on visionary concepts.
The last decade made collaboration essential. Research doesn’t happen in a vacuum; teams bring in university chemists, biotech startups, and established pharmaceutical companies. The expansion of online marketplaces for reagents only accelerated this trend, breaking down geographic and institutional barriers. More researchers now access high-purity 7-Bromoquinoxalin-2(1H)-one, making cross-border cooperation on drug discovery or sensor development not just possible but practical.
With reliable sources, scientific progress sheds the persistent worry over contaminated or mislabeled intermediates. Labs running parallel projects across continents can rely on lot-supplied product data, full certificates of analysis, and the shared vocabulary of spectral confirmation. Problems in reproducibility—a haunting issue in contemporary science—shrink when intermediates prove robust, consistent, and validated across user groups. This shared confidence allows attention to return to creative problem-solving, hypothesis testing, and real innovation.
Of course, even robust compounds carry limitations. Supply chain interruptions, especially for specialty chemicals with limited demand, have stymied more than a few research initiatives. Pricing remains a live concern, particularly for academic labs juggling ever-tighter budgets. As demand rises in specialized markets, bulk synthesis routes, improved distribution channels, and supportive supplier relationships become crucial. Chemical producers seeking to broaden access focus on greener, more efficient synthetic routes—minimizing costs and bolstering supply resilience.
Handling and toxicological data for many quinoxaline derivatives, especially newer analogs, remain incomplete. A responsible research culture avoids over-promising applications without sufficient safety and environmental data. Open sharing of new studies, hazard assessments, and disposal protocols serves not just immediate users but also the broader community downstream—students, technicians, and future researchers.
Relying on intermediates like 7-Bromoquinoxalin-2(1H)-one, researchers can tackle common obstacles with coordinated effort. One direct approach: develop clearer, step-by-step application notes based on open data, including common troubleshooting advice. Many labs run into issues only solved by collective memory—guidance from others who have already navigated Suzuki or Buchwald-Hartwig couplings on these systems. Blog posts, forums, and collaborative papers foster transparency, arming chemists with tactics for boosting yields and reducing purification bottlenecks.
Building institutional partnerships lets academic labs tap into industry-scale expertise. Joint workshops train students and postdocs not just how to use advanced intermediates but also how to maximize return on investment—driving each milligram further in the search for meaningful data. For manufacturers, offering live technical support or participating in online user groups directly addresses the skill gap as new researchers join the field.
At a policy level, suppliers who focus on detailed chemical traceability, long-term availability commitments, and real-time purity data give peace of mind to research directors and lab managers tasked with continuity planning. As regulations tighten and expectations for environmental and worker safety ramp up, prioritizing sustainable manufacturing practices only strengthens trust and market presence.
The case for 7-Bromoquinoxalin-2(1H)-one doesn’t hang on singular breakthroughs or theoretical potential. Track records matter here. Pulling from direct experience and widespread discussions in the scientific community, access to top-tier chemical intermediates accelerates progress across medical chemistry, diagnostics, materials, and sustainable processes. Every new patent, publication, or prototype draws from the groundwork set by chemists who value reliability and adaptability in the search for better solutions.
7-Bromoquinoxalin-2(1H)-one sits not at the heart of any single technology but plays a supporting role in dozens, greasing the wheels of creative synthesis and interdisciplinary collaboration. Gaps in supply, cost, or data motivate researchers and suppliers alike to share expertise, sharpen protocols, and invest in smarter manufacturing. The shared push to refine, test, and deploy building blocks like this not only improves outcomes in the lab—it also lays foundations for future discoveries that stretch well beyond the bench.